{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:06:58Z","timestamp":1784225218487,"version":"3.55.0"},"publisher-location":"Berlin, Heidelberg","reference-count":96,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/164_2026_822","type":"book-chapter","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:43:36Z","timestamp":1784223816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TAAR1 Potential for Treatment of Stress Disorders"],"prefix":"10.1007","author":[{"given":"Ziqi","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Nong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"822_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ijnp\/pyad049","volume":"26","author":"R \u00c5gren","year":"2023","unstructured":"\u00c5gren R, Betari N, Saarinen M, Zeberg H, Svenningsson P, Sahlholm K (2023) In vitro comparison of ulotaront (SEP-363856) and ralmitaront (RO6889450): two TAAR1 agonist candidate antipsychotics. Int J Neuropsychopharmacol 26:599\u2013606","journal-title":"Int J Neuropsychopharmacol"},{"key":"822_CR2","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.1312-15.2015","volume":"35","author":"A Alvarsson","year":"2015","unstructured":"Alvarsson A, Zhang XQ, Stan TL, Schintu N, Kadkhodaei B, Millan MJ, Perlmann T, Svenningsson P (2015) Modulation by trace amine-associated receptor 1 of experimental parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission. J Neurosci 35:14057\u201314069","journal-title":"J Neurosci"},{"key":"822_CR3","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","volume":"106","author":"B Amyaouch","year":"2009","unstructured":"Amyaouch B, Gerhard T, Henri S, Roger DN, Laurence O, Joseph GW, Audr\u00e9e P, Dani\u00e8le B, Martin G, Marius CH, Bernhard B (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106:20081","journal-title":"Proc Natl Acad Sci USA"},{"key":"822_CR4","doi-asserted-by":"crossref","first-page":"13901","DOI":"10.1038\/s41598-017-14472-z","volume":"7","author":"A Asif-Malik","year":"2017","unstructured":"Asif-Malik A, Hoener MC, Canales JJ (2017) Interaction between the trace amine-associated receptor 1 and the dopamine D2 receptor controls Cocaine's neurochemical actions. Sci rep-UK 7:13901","journal-title":"Sci rep-UK"},{"key":"822_CR5","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/0006-2952(73)90147-0","volume":"22","author":"AJ Azzaro","year":"1973","unstructured":"Azzaro AJ, Rutledge CO (1973) Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain. Biochem Pharmacol 22:2801\u20132813","journal-title":"Biochem Pharmacol"},{"key":"822_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00979534","volume":"12","author":"BA Bailey","year":"1987","unstructured":"Bailey BA, Philips SR, Boulton AA (1987) In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine. Neurochem Res 12:173\u2013178","journal-title":"Neurochem Res"},{"key":"822_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","volume":"17","author":"B Bandelow","year":"2015","unstructured":"Bandelow B, Michaelis S (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 17:327\u2013335","journal-title":"Dialogues Clin Neurosci"},{"key":"822_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pharmthera.2017.07.002","volume":"180","author":"MD Berry","year":"2017","unstructured":"Berry MD, Gainetdinov RR, Hoener MC, Shahid M (2017) Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges. Pharmacol Therapeut 180:161\u2013180","journal-title":"Pharmacol Therapeut"},{"key":"822_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01249880","volume":"59","author":"W Birkmayer","year":"1984","unstructured":"Birkmayer W, Riederer P, Linauer W, Knoll J (1984) L-deprenyl plus L-phenylalanine in the treatment of depression. J Neural Transm 59:81\u201387","journal-title":"J Neural Transm"},{"key":"822_CR10","volume":"351","author":"JI Bisson","year":"2015","unstructured":"Bisson JI, Cosgrove S, Lewis C, Robert NP (2015) Post-traumatic stress disorder. Bmj 351:h6161","journal-title":"Bmj"},{"key":"822_CR11","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1038\/npp.2009.118","volume":"34","author":"M Bortolato","year":"2009","unstructured":"Bortolato M, Godar SC, Davarian S, Chen K, Shih JC (2009) Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 34:2746\u20132757","journal-title":"Neuropsychopharmacology"},{"key":"822_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0140-6736(74)91390-7","volume":"2","author":"AA Boulton","year":"1974","unstructured":"Boulton AA (1974) Letter: amines and theories in psychiatry. Lancet 2:52\u201353","journal-title":"Lancet"},{"key":"822_CR13","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","volume":"106","author":"A Bradaia","year":"2009","unstructured":"Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG, Pinard A, Buchy D, Gassmann M, Hoener MC, Bettler B (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106:20081\u201320086","journal-title":"Proc Natl Acad Sci USA"},{"key":"822_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10571-019-00772-7","volume":"40","author":"K Bugda Gwilt","year":"2020","unstructured":"Bugda Gwilt K, Gonz\u00e1lez DP, Olliffe N, Oller H, Hoffing R, Puzan M, El Aidy S, Miller GM (2020) Actions of trace amines in the brain-gut-microbiome axis via trace amine-associated receptor-1 (TAAR1). Cell Mol Neurobiol 40:191\u2013201","journal-title":"Cell Mol Neurobiol"},{"key":"822_CR15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","volume":"60","author":"JR Bunzow","year":"2001","unstructured":"Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181\u20131188","journal-title":"Mol Pharmacol"},{"key":"822_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"Collaborators GMD","year":"2022","unstructured":"Collaborators GMD (2022) Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9:137\u2013150","journal-title":"Lancet Psychiatry"},{"key":"822_CR17","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.3390\/ijms23147811","volume":"23","author":"L Damiana","year":"2022","unstructured":"Damiana L, Giorgia T, Stefano E, Agn\u00e8s V, Raul RG, Laurence R (2022) Trace amine associate receptor 1 (TAAR1) as a new target for the treatment of cognitive dysfunction in Alzheimer's disease. Int J Mol Sci 23:7811","journal-title":"Int J Mol Sci"},{"issue":"Suppl 6","key":"822_CR18","first-page":"7","volume":"61","author":"PL Delgado","year":"2000","unstructured":"Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatry 61(Suppl 6):7\u201311","journal-title":"J Clin Psychiatry"},{"key":"822_CR19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/mol.111.073304","volume":"80","author":"S Espinoza","year":"2011","unstructured":"Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80:416\u2013425","journal-title":"Mol Pharmacol"},{"key":"822_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.02.010","volume":"93","author":"S Espinoza","year":"2015","unstructured":"Espinoza S, Ghisi V, Emanuele M, Leo D, Sukhanov I, Sotnikova TD, Chieregatti E, Gainetdinov RR (2015a) Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology 93:308\u2013313","journal-title":"Neuropharmacology"},{"key":"822_CR21","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/npp.2015.65","volume":"40","author":"S Espinoza","year":"2015","unstructured":"Espinoza S, Lignani G, Caffino L, Maggi S, Sukhanov I, Leo D, Mus L, Emanuele M, Ronzitti G, Harmeier A, Medrihan L, Sotnikova TD, Chieregatti E, Hoener MC, Benfenati F, Tucci V, Fumagalli F, Gainetdinov RR (2015b) TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40:2217\u20132227","journal-title":"Neuropsychopharmacology"},{"key":"822_CR22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00645","volume":"9","author":"S Espinoza","year":"2018","unstructured":"Espinoza S, Leo D, Sotnikova TD, Shahid M, K\u00e4\u00e4ri\u00e4inen TM, Gainetdinov RR (2018) Biochemical and functional characterization of the trace amine-associated receptor 1 (TAAR1) agonist RO5263397. Front Pharmacol 9:645","journal-title":"Front Pharmacol"},{"key":"822_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-3565(25)31549-1","volume":"208","author":"JF Fischer","year":"1979","unstructured":"Fischer JF, Cho AK (1979) Chemical-release of dopamine from striatal homogenates - evidence for an exchange diffusion-model. J Pharmacol Exp Ther 208:203\u2013209","journal-title":"J Pharmacol Exp Ther"},{"key":"822_CR24","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","volume":"108","author":"GR Florent","year":"2011","unstructured":"Florent GR, Jean-Luc M, Raul RG, Amyaouch B, Tatyana DS, Roland M, Sean D, Katrin Groebke Z, Roger N, Claas AM, Veit M, Sylvie C, Laurence O, Gerhard T, Bruno P, Bernhard B, Marc GC, Joseph GW, Marius CH (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108:8485","journal-title":"Proc Natl Acad Sci USA"},{"key":"822_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.117.015305","volume":"70","author":"RR Gainetdinov","year":"2018","unstructured":"Gainetdinov RR, Hoener MC, Berry MD (2018) Trace amines and their receptors. Pharmacol Rev 70:549\u2013620","journal-title":"Pharmacol Rev"},{"key":"822_CR26","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.14-10-06084.1994","volume":"14","author":"PA Garris","year":"1994","unstructured":"Garris PA, Ciolkowski EL, Pastore P, Wightman RM (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14:6084\u20136093","journal-title":"J Neurosci"},{"key":"822_CR27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00127-016-1208-5","volume":"51","author":"RB Goldstein","year":"2016","unstructured":"Goldstein RB, Smith SM, Chou SP, Saha TD, Jung J, Zhang H, Pickering RP, Ruan WJ, Huang B, Grant BF (2016) The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Soc Psychiatry Psychiatr Epidemiol 51:1137\u20131148","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"822_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0447.1988.tb06325.x","volume":"78","author":"F Gonz\u00e1lez-Sastre","year":"1988","unstructured":"Gonz\u00e1lez-Sastre F, Mora J, Guillamat R, Queralt\u00f3 JM, Alvarez E, Udina C, Massana J (1988) Urinary phenylacetic acid excretion in depressive patients. Acta Psychiatr Scand 78:208\u2013210","journal-title":"Acta Psychiatr Scand"},{"key":"822_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2007.06.007","volume":"116","author":"DK Grandy","year":"2007","unstructured":"Grandy DK (2007) Trace amine-associated receptor 1-family archetype or iconoclast? Pharmacol Ther 116:355\u2013390","journal-title":"Pharmacol Ther"},{"key":"822_CR30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3389\/fphar.2017.00987","volume":"8","author":"R Grazia","year":"2018","unstructured":"Grazia R, Alice A, Riccardo Z (2018) The case for TAAR1 as a modulator of central nervous system function. Front Pharmacol 8:987","journal-title":"Front Pharmacol"},{"key":"822_CR31","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1038\/s41380-022-01739-9","volume":"27","author":"D Grinchii","year":"2022","unstructured":"Grinchii D, Hoener MC, Khoury T, Dekhtiarenko R, Nejati Bervanlou R, Jezova D, Dremencov E (2022) Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats. Mol Psychiatry 27:4861\u20134868","journal-title":"Mol Psychiatry"},{"key":"822_CR32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tins.2022.10.010","volume":"46","author":"EF Halff","year":"2023","unstructured":"Halff EF, Rutigliano G, Garcia-Hidalgo A, Howes OD (2023) Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. Trends Neurosci 46:60\u201374","journal-title":"Trends Neurosci"},{"key":"822_CR33","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.euroneuro.2015.08.011","volume":"25","author":"A Harmeier","year":"2015","unstructured":"Harmeier A, Obermueller S, Meyer CA, Revel FG, Buchy D, Chaboz S, Dernick G, Wettstein JG, Iglesias A, Rolink A, Bettler B, Hoener MC (2015) Trace amine-associated receptor 1 activation silences GSK3\u03b2 signaling of TAAR1 and D2R heteromers. Eur Neuropsychopharmacol 25:2049\u20132061","journal-title":"Eur Neuropsychopharmacol"},{"key":"822_CR34","first-page":"335","volume":"9","author":"M Hirano","year":"1989","unstructured":"Hirano M, Uchimura H, Shiraishi A, Kuroki T, Matsumoto T, Tsutsumi T (1989) beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics. Yakubutsu Seishin Kodo 9:335\u2013348","journal-title":"Yakubutsu Seishin Kodo"},{"key":"822_CR35","first-page":"206","volume":"103","author":"S Ilya","year":"2015","unstructured":"Ilya S, Lucia C, Evgeniya VE, Stefano E, Tatiana DS, Luigi C, Fabio F, Raul RG (2015) Increased context-dependent conditioning to amphetamine in mice lacking TAAR1. Pharmacol Res 103:206","journal-title":"Pharmacol Res"},{"key":"822_CR36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","volume":"78","author":"DC Javitt","year":"2007","unstructured":"Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78:69\u2013108","journal-title":"Int Rev Neurobiol"},{"key":"822_CR37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1176\/appi.ajp.20230025","volume":"180","author":"MK Jha","year":"2023","unstructured":"Jha MK, Mathew SJ (2023) Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry 180:190\u2013199","journal-title":"Am J Psychiatry"},{"key":"822_CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","volume":"21","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU (2012) Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 21:169\u2013184","journal-title":"Int J Methods Psychiatr Res"},{"key":"822_CR39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1017\/S2045796015000189","volume":"24","author":"RC Kessler","year":"2015","unstructured":"Kessler RC, Sampson NA, Berglund P, Gruber MJ, Al-Hamzawi A, Andrade L, Bunting B, Demyttenaere K, Florescu S, de Girolamo G, Gureje O, He Y, Hu C, Huang Y, Karam E, Kovess-Masfety V, Lee S, Levinson D, Medina Mora ME, Moskalewicz J, Nakamura Y, Navarro-Mateu F, Browne MA, Piazza M, Posada-Villa J, Slade T, Ten Have M, Torres Y, Vilagut G, Xavier M, Zarkov Z, Shahly V, Wilcox MA (2015) Anxious and non-anxious major depressive disorder in the World Health Organization world mental health surveys. Epidemiol Psychiatr Sci 24:210\u2013226","journal-title":"Epidemiol Psychiatr Sci"},{"key":"822_CR40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1248\/bpb.28.1626","volume":"28","author":"I Kota","year":"2005","unstructured":"Kota I, Mikio M, Masatoshi K, Iku U, Keiko H, Kyoji T (2005) Beta-phenylethylamine stimulates striatal acetylcholine release through activation of the AMPA glutamatergic pathway. Biol Pharm Bull 28:1626","journal-title":"Biol Pharm Bull"},{"key":"822_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.10m06176blu","volume":"72","author":"F Lamers","year":"2011","unstructured":"Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, Nolen WA, Zitman FG, Beekman AT, Penninx BW (2011) Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands study of depression and anxiety (NESDA). J Clin Psychiatry 72:341\u2013348","journal-title":"J Clin Psychiatry"},{"key":"822_CR42","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.3390\/ijms21239103","volume":"21","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Kim HR, Lee CY, Hyun SA, Ko MY, Lee BS, Hwang DY, Ka M (2020) 2-Phenylethylamine (PEA) ameliorates corticosterone-induced depression-like phenotype via the BDNF\/TrkB\/CREB signaling pathway. Int J Mol Sci 21:9103","journal-title":"Int J Mol Sci"},{"key":"822_CR43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2014.02.007","volume":"81","author":"D Leo","year":"2014","unstructured":"Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR (2014) Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology 81:283\u2013291","journal-title":"Neuropharmacology"},{"key":"822_CR44","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.1931-17.2018","volume":"38","author":"D Leo","year":"2018","unstructured":"Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, Messa G, Emanuele M, Esposito A, Dorofeikova M, Budygin EA, Mus L, Efimova EV, Niello M, Espinoza S, Sotnikova TD, Hoener MC, Laviola G, Fumagalli F, Adriani W, Gainetdinov RR (2018) Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats. J Neurosci 38:1959\u20131972","journal-title":"J Neurosci"},{"key":"822_CR45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/15622975.2024.2429507","volume":"25","author":"M Li","year":"2024","unstructured":"Li M, Yang Y, Xu G, Gu J, Zhang Y, Maes M, Liu H (2024) SEP-363856 attenuates CUMS-induced depression-like behaviours and reverses hippocampal neuronal injuries. World J Biol Psychiatry 25:604\u2013621","journal-title":"World J Biol Psychiatry"},{"key":"822_CR46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fphar.2018.00279","volume":"9","author":"JF Liu","year":"2018","unstructured":"Liu JF, Li JX (2018) TAAR1 in addiction: looking beyond the tip of the iceberg. Front Pharmacol 9:279","journal-title":"Front Pharmacol"},{"key":"822_CR47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.mp.4002037","volume":"12","author":"C Liu","year":"2007","unstructured":"Liu C, Shi J, Badner JA, Zou H, Qian Y, Gershon ES (2007) No association of trace amine receptor genes with bipolar disorder. Mol Psychiatry 12:979\u2013981","journal-title":"Mol Psychiatry"},{"key":"822_CR48","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41380-022-01448-3","volume":"27","author":"J Liu","year":"2022","unstructured":"Liu J, Wu R, Seaman R Jr, Manz KM, Johnson B, Vu J, Huang Y, Zhang Y, Robison AJ, Neve R, Grueter BA, Dietz D, Li JX (2022) TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKII\u03b1 activity in the NAc. Mol Psychiatry 27:2136\u20132145","journal-title":"Mol Psychiatry"},{"key":"822_CR49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2025.08.025","volume":"584","author":"DN Liu","year":"2025","unstructured":"Liu DN, Sun M, Zhang XQ, Li JT, Si TM, Su YA (2025) A quantitative analysis of TAAR1-positive cells in whole mouse brain by FDISCO technology. Neuroscience 584:286\u2013294","journal-title":"Neuroscience"},{"key":"822_CR50","doi-asserted-by":"crossref","first-page":"119364","DOI":"10.1016\/j.lfs.2021.119364","volume":"275","author":"TL Ma","year":"2021","unstructured":"Ma TL, Zhou Y, Zhang CY, Gao ZA, Duan JX (2021) The role and mechanism of \u03b2-arrestin2 in signal transduction. Life Sci 275:119364","journal-title":"Life Sci"},{"key":"822_CR51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biopsych.2020.12.008","volume":"90","author":"I Mantas","year":"2021","unstructured":"Mantas I, Vallianatou T, Yang Y, Shariatgorji M, Kalomoiri M, Fridjonsdottir E, Millan MJ, Zhang X, Andr\u00e9n PE, Svenningsson P (2021) TAAR1-dependent and -independent actions of tyramine in interaction with glutamate underlie central effects of monoamine oxidase inhibition. Biol Psychiatry 90:16\u201327","journal-title":"Biol Psychiatry"},{"key":"822_CR52","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","volume":"396","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Berk M, Brietzke E, Goldstein BI, L\u00f3pez-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB (2020) Bipolar disorders. Lancet 396:1841\u20131856","journal-title":"Lancet"},{"key":"822_CR53","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0006-3223(95)00045-3","volume":"38","author":"KR Merikangas","year":"1995","unstructured":"Merikangas KR, Stevens DE, Merikangas JR, Katz CB, Glover V, Cooper T, Sandler M (1995) Tyramine conjugation deficit in migraine, tension-type headache, and depression. Biol Psychiatry 38:730\u2013736","journal-title":"Biol Psychiatry"},{"key":"822_CR54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1086\/420775","volume":"74","author":"FA Middleton","year":"2004","unstructured":"Middleton FA, Pato MT, Gentile KL, Morley CP, Zhao X, Eisener AF, Brown A, Petryshen TL, Kirby AN, Medeiros H, Carvalho C, Macedo A, Dourado A, Coelho I, Valente J, Soares MJ, Ferreira CP, Lei M, Azevedo MH, Kennedy JL, Daly MJ, Sklar P, Pato CN (2004) Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 74:886\u2013897","journal-title":"Am J Hum Genet"},{"key":"822_CR55","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/brainsci12121639","volume":"12","author":"G-K Nane","year":"2022","unstructured":"Nane G-K, Andrew NC, Petrine W (2022) CaMKII\u03b1 as a promising drug target for ischemic grey matter. Brain Sci 12:1639","journal-title":"Brain Sci"},{"key":"822_CR56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1087057106289891","volume":"11","author":"HA Navarro","year":"2006","unstructured":"Navarro HA, Gilmour BP, Lewin AH (2006) A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium. J Biomol Screen 11:688\u2013693","journal-title":"J Biomol Screen"},{"key":"822_CR57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neulet.2009.09.025","volume":"465","author":"CU Pae","year":"2009","unstructured":"Pae CU, Drago A, Mandelli L, De Ronchi D, Serretti A (2009) TAAR 6 and HSP-70 variations associated with bipolar disorder. Neurosci Lett 465:257\u2013261","journal-title":"Neurosci Lett"},{"key":"822_CR58","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/BF00975055","volume":"18","author":"IA Paterson","year":"1993","unstructured":"Paterson IA (1993) The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline. Neurochem Res 18:1329\u20131336","journal-title":"Neurochem Res"},{"key":"822_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116236","volume":"228","author":"L Peng","year":"2024","unstructured":"Peng L, Zhang J, Feng J, Ge J, Zou Y, Chen Y, Xu L, Zeng Y, Li JX, Liu J (2024) Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms. Biochem Pharmacol 228:116236","journal-title":"Biochem Pharmacol"},{"key":"822_CR60","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S2215-0366(23)00262-6","volume":"10","author":"T Pillinger","year":"2023","unstructured":"Pillinger T, Howes OD, Correll CU, Leucht S, Huhn M, Schneider-Thoma J, Gaughran F, Jauhar S, McGuire PK, Taylor DM, Young AH, McCutcheon RA (2023) Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development. Lancet Psychiatry 10:860\u2013876","journal-title":"Lancet Psychiatry"},{"key":"822_CR61","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110555","volume":"117","author":"\u00cd Raony","year":"2022","unstructured":"Raony \u00cd, Domith I, Lourenco MV, Paes-de-Carvalho R, Pandolfo P (2022) Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD. Prog Neuro-Psychopharmacol Biol Psychiatry 117:110555","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"822_CR62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.106.115402","volume":"321","author":"EA Reese","year":"2007","unstructured":"Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK (2007) Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J Pharmacol Exp Ther 321:178\u2013186","journal-title":"J Pharmacol Exp Ther"},{"key":"822_CR63","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/molecules27092755","volume":"27","author":"X Ren","year":"2022","unstructured":"Ren X, Xiong J, Liang L, Chen Y, Zhang G (2022) The potential antidepressant action of duloxetine co-administered with the TAAR1 receptor agonist SEP-363856 in mice. Molecules 27:2755","journal-title":"Molecules"},{"key":"822_CR64","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","volume":"108","author":"FG Revel","year":"2011","unstructured":"Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108:8485\u20138490","journal-title":"Proc Natl Acad Sci USA"},{"key":"822_CR65","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1038\/npp.2012.109","volume":"37","author":"FG Revel","year":"2012","unstructured":"Revel FG, Meyer CA, Bradaia A, Jeanneau K, Calcagno E, Andr\u00e9 CB, Haenggi M, Miss MT, Galley G, Norcross RD, Invernizzi RW, Wettstein JG, Moreau JL, Hoener MC (2012a) Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37:2580\u20132592","journal-title":"Neuropsychopharmacology"},{"key":"822_CR66","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","volume":"72","author":"FG Revel","year":"2012","unstructured":"Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Vel\u00e1zquez-S\u00e1nchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, Canales JJ, Wallace TL, Wettstein JG, Hoener MC (2012b) Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72:934\u2013942","journal-title":"Biol Psychiatry"},{"key":"822_CR67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","volume":"18","author":"FG Revel","year":"2013","unstructured":"Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR, Kilduff TS, Wallace TL, Risterucci C, Wettstein JG, Hoener MC (2013) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18:543\u2013556","journal-title":"Mol Psychiatry"},{"key":"822_CR68","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01027","volume":"10","author":"G Rutigliano","year":"2019","unstructured":"Rutigliano G, Br\u00e4unig J, Del Grande C, Carnicelli V, Masci I, Merlino S, Kleinau G, Tessieri L, Pardossi S, Paisdzior S, Dell'Osso L, Biebermann H, Zucchi R (2019) Non-functional trace amine-associated receptor 1 variants in patients with mental disorders. Front Pharmacol 10:1027","journal-title":"Front Pharmacol"},{"key":"822_CR69","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1126\/science.6857245","volume":"220","author":"HC Sabelli","year":"1983","unstructured":"Sabelli HC, Fawcett J, Gusovsky F, Javaid J, Edwards J, Jeffriess H (1983) Urinary phenyl acetate: a diagnostic test for depression? Science 220:1187\u20131188","journal-title":"Science"},{"key":"822_CR70","first-page":"66","volume":"47","author":"HC Sabelli","year":"1986","unstructured":"Sabelli HC, Fawcett J, Gusovsky F, Javaid JI, Wynn P, Edwards J, Jeffriess H, Kravitz H (1986) Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry 47:66\u201370","journal-title":"J Clin Psychiatry"},{"key":"822_CR71","first-page":"537","volume":"120","author":"D Seetal","year":"2020","unstructured":"Seetal D, Andr\u00e9 FC, Basant KP, Michael M, Chiara CB, Gerwyn M, Michael B (2020) Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry? Neurosci Biobehav Rev 120:537","journal-title":"Neurosci Biobehav Rev"},{"key":"822_CR72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1099\/00221287-55-2-195","volume":"55","author":"K Sen","year":"1969","unstructured":"Sen K, Nandi P, Mishra AK (1969) Transformation of nutritionally deficient mutants of Aspergillus niger. J Gen Microbiol 55:195\u2013200","journal-title":"J Gen Microbiol"},{"key":"822_CR73","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1016\/j.cell.2023.10.014","volume":"186","author":"P Shang","year":"2023","unstructured":"Shang P, Rong N, Jiang JJ, Cheng J, Zhang MH, Kang D, Qi L, Guo L, Yang GM, Liu Q, Zhou Z, Li XB, Zhu KK, Meng QB, Han X, Yan W, Kong Y, Yang L, Wang X, Lei D, Feng X, Liu X, Yu X, Wang Y, Li Q, Shao ZH, Yang F, Sun JP (2023) Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell 186:5347\u20135362.e24","journal-title":"Cell"},{"key":"822_CR74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.c.20013","volume":"123c","author":"JW Smoller","year":"2003","unstructured":"Smoller JW, Finn CT (2003) Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 123c:48\u201358","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"822_CR75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-8993(86)91317-X","volume":"366","author":"JA Stamford","year":"1986","unstructured":"Stamford JA, Kruk Z, Millar J (1986) An in vivo voltammetric comparison of the effects of three psychomotor stimulants on electrically evoked neostriatal dopamine release. Brain Res 366:350\u2013353","journal-title":"Brain Res"},{"key":"822_CR76","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/npp.2015.65","volume":"40","author":"E Stefano","year":"2015","unstructured":"Stefano E, Gabriele L, Lucia C, Silvia M, Ilya S, Damiana L, Liudmila M, Marco E, Giuseppe R, Anja H, Lucian M, Tatyana DS, Evelina C, Marius CH, Fabio B, Valter T, Fabio F, Raul RG (2015) TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40:2217","journal-title":"Neuropsychopharmacology"},{"key":"822_CR77","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41386-024-01866-7","volume":"49","author":"M Sun","year":"2024","unstructured":"Sun M, Zhang Y, Zhang XQ, Zhang Y, Wang XD, Li JT, Si TM, Su YA (2024) Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits. Neuropsychopharmacology 49:1341\u20131351","journal-title":"Neuropsychopharmacology"},{"key":"822_CR78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1242\/jeb.196.1.229","volume":"196","author":"GR Uhl","year":"1994","unstructured":"Uhl GR, Johnson PS (1994) Neurotransmitter transporters: three important gene families for neuronal function. J Exp Biol 196:229\u2013236","journal-title":"J Exp Biol"},{"key":"822_CR79","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuron.2014.05.043","volume":"83","author":"SM Underhill","year":"2014","unstructured":"Underhill SM, Wheeler DS, Li M, Watts SD, Ingram SL, Amara SG (2014) Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons. Neuron 83:404\u2013416","journal-title":"Neuron"},{"key":"822_CR80","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41380-019-0469-2","volume":"26","author":"SM Underhill","year":"2021","unstructured":"Underhill SM, Hullihen PD, Chen J, Fenollar-Ferrer C, Rizzo MA, Ingram SL, Amara SG (2021) Amphetamines signal through intracellular TAAR1 receptors coupled to G\u03b1(13) and G\u03b1(S) in discrete subcellular domains. Mol Psychiatry 26:1208\u20131223","journal-title":"Mol Psychiatry"},{"key":"822_CR81","first-page":"E2517","volume":"112","author":"NM Urs","year":"2015","unstructured":"Urs NM, Bido S, Peterson SM, Daigle TL, Bass CE, Gainetdinov RR, Bezard E, Caron MG (2015) Targeting \u03b2-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease. P Natl Acad Sci USA 112:E2517\u2013E2526","journal-title":"P Natl Acad Sci USA"},{"key":"822_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ypg.0000180682.18665.a6","volume":"16","author":"T Venken","year":"2006","unstructured":"Venken T, Alaerts M, Adolfsson R, Broeckhoven CV, Del-Favero J (2006) No association of the trace amine-associated receptor 6 with bipolar disorder in a northern Swedish population. Psychiatr Genet 16:1\u20132","journal-title":"Psychiatr Genet"},{"key":"822_CR83","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.106.112532","volume":"320","author":"DB Wainscott","year":"2007","unstructured":"Wainscott DB, Little SP, Yin T, Tu Y, Rocco VP, He JX, Nelson DL (2007) Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. J Pharmacol Exp Ther 320:475\u2013485","journal-title":"J Pharmacol Exp Ther"},{"key":"822_CR84","doi-asserted-by":"crossref","first-page":"E7138","DOI":"10.1073\/pnas.1511670112","volume":"112","author":"DS Wheeler","year":"2015","unstructured":"Wheeler DS, Underhill SM, Stolz DB, Murdoch GH, Thiels E, Romero G, Amara SG (2015) Amphetamine activates rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Proc Natl Acad Sci USA 112:E7138\u2013E7147","journal-title":"Proc Natl Acad Sci USA"},{"key":"822_CR85","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","volume":"6","author":"TD Wolinsky","year":"2007","unstructured":"Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, Gerald CP (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628\u2013639","journal-title":"Genes Brain Behav"},{"key":"822_CR86","volume":"27","author":"R Wu","year":"2022","unstructured":"Wu R, Liu J, Johnson B, Huang Y, Zhang Y, Li JX (2022) Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects. Addict Biol 27:e13075","journal-title":"Addict Biol"},{"key":"822_CR87","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.106.117382","volume":"321","author":"Z Xie","year":"2007","unstructured":"Xie Z, Miller GM (2007) Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321:128\u2013136","journal-title":"J Pharmacol Exp Ther"},{"key":"822_CR88","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/jpet.107.134247","volume":"325","author":"Z Xie","year":"2008","unstructured":"Xie Z, Miller GM (2008) Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. J Pharmacol Exp Ther 325:617\u2013628","journal-title":"J Pharmacol Exp Ther"},{"key":"822_CR89","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.106.116863","volume":"321","author":"Z Xie","year":"2007","unstructured":"Xie Z, Westmoreland SV, Bahn ME, Chen GL, Yang H, Vallender EJ, Yao WD, Madras BK, Miller GM (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321:116\u2013127","journal-title":"J Pharmacol Exp Ther"},{"key":"822_CR90","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-023-06804-z","volume":"624","author":"Z Xu","year":"2023","unstructured":"Xu Z, Guo L, Yu J, Shen S, Wu C, Zhang W, Zhao C, Deng Y, Tian X, Feng Y, Hou H, Su L, Wang H, Guo S, Wang H, Wang K, Chen P, Zhao J, Zhang X, Yong X, Cheng L, Liu L, Yang S, Yang F, Wang X, Yu X, Xu Y, Sun JP, Yan W, Shao Z (2023) Ligand recognition and G-protein coupling of trace amine receptor TAAR1. Nature 624:672\u2013681","journal-title":"Nature"},{"key":"822_CR91","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/s41467-023-38180-7","volume":"14","author":"SH Yang","year":"2023","unstructured":"Yang SH, Yang E, Lee J, Kim JY, Yoo H, Park HS, Jung JT, Lee D, Chun S, Jo YS, Pyeon GH, Park JY, Lee HW, Kim H (2023) Neural mechanism of acute stress regulation by trace aminergic signalling in the lateral habenula in male mice. Nat Commun 14:2435","journal-title":"Nat Commun"},{"key":"822_CR92","doi-asserted-by":"crossref","first-page":"396","DOI":"10.25082\/JPBR.2023.01.004","volume":"5","author":"L Yu","year":"2024","unstructured":"Yu L, Zhang W, Shi Y, Zhang Y, Xu M, Xu Y, Li C, Tian J (2024) TAAR1 as a new target for the treatment of bipolar disorder: anti-manic and anti-depressant activity of the novel agonist PCC0105004. J Pharm Biopharm Res 5:396","journal-title":"J Pharm Biopharm Res"},{"key":"822_CR93","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1038\/s41467-023-40552-y","volume":"14","author":"L Zhai","year":"2023","unstructured":"Zhai L, Xiao H, Lin C, Wong HLX, Lam YY, Gong M, Wu G, Ning Z, Huang C, Zhang Y, Yang C, Luo J, Zhang L, Zhao L, Zhang C, Lau JY-N, Lu A, Lau L-T, Jia W, Zhao L, Bian Z-X (2023) Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome. Nat Commun 14:4986","journal-title":"Nat Commun"},{"key":"822_CR94","volume":"167","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li JT, Wang H, Niu WP, Zhang CC, Zhang Y, Wang XD, Si TM, Su YA (2021) Role of trace amine-associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice. Pharmacol Res 167:105571","journal-title":"Pharmacol Res"},{"key":"822_CR95","volume":"132","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang XQ, Niu WP, Sun M, Zhang Y, Li JT, Si TM, Su YA (2024) TAAR1 in dentate gyrus is involved in chronic stress-induced impairments in hippocampal plasticity and cognitive function. Prog Neuro-Psychopharmacol Biol Psychiatry 132:110995","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"822_CR96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41398-025-03727-3","volume":"15","author":"XQ Zhang","year":"2025","unstructured":"Zhang XQ, Xiong J, Liu DN, Zhang CC, Zhang Y, Li JT, Si TM, Su YA (2025) TAAR1 deficiency impairs mitochondrial dynamics and synaptic integrity in the medial prefrontal cortex and associated cognition in mice. Transl Psychiatry 15:490","journal-title":"Transl Psychiatry"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2026_822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:43:49Z","timestamp":1784223829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2026_822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":96,"URL":"https:\/\/doi.org\/10.1007\/164_2026_822","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"17 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}